Lasa Supergenerics Ltd
Ticker: LASA
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
10.22
Market Cap
51.20
Debt/Equity
0.2284
ROE %
-20.218
PB
0.5296
Promoter %
53.651
Pledge %
11.085
1Y Rev Growth %
41.191
5Y Rev Growth %
-2.515
NP Margin %
-10.003
NP Margin 5Y Avg %
-10.564
Trading Reference
1M Return %
-14.107
6M Return %
-41.932
1Y Return %
-63.707
% Away 52W High
207.241
% Away 52W Low
25.245
Daily Volume
60119
Investment Verdict
Risky
Score 58/100 · Position size: 6%
Higher volatility/weak areas. Consider only a small allocation if risk appetite is high.
Trading Verdict
Avoid
Score 8/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Lasa Supergenerics Ltd is currently trading near a key support level, with the 50-day EMA indicating a potential upward trend if it breaks above the resistance at 150. Volume has been increasing, suggesting strong buying interest. Therefore, there is a favorable outlook for a price increase in the medium term.
Upside Probability: 20% | Downside Probability: 10%
Probability estimates are technical-context statements, not investment advice.
More Options
C
Ceeta Industries Ltd
Ceeta Industries Ltd shows some potential but faces significant challenges in profitability and valuation metrics.
View details
K
Khaitan (India) Ltd
Khaitan (India) Ltd presents a mixed outlook with some growth potential but significant risks and inconsistencies in performance metrics.
View details
C
CCL International Ltd
CCL International Ltd shows potential but is currently facing significant risks and inconsistencies in growth and profitability.
View details
H
Hilltone Software and Gases Ltd
Hilltone Software and Gases Ltd presents several risks with limited growth prospects and weak financials.
View details
S
Shantidoot Infra Services Ltd
Shantidoot Infra Services Ltd presents several risks, particularly in profitability and balance sheet strength, making it a risky investment at this time.
View details
B
BDR Buildcon Ltd
BDR Buildcon Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
A
Alfa Transformers Ltd
Alfa Transformers Ltd shows potential for growth in a stable industry, but faces challenges in profitability and valuation metrics.
View details
N
National Oxygen Ltd
National Oxygen Ltd shows moderate potential but faces challenges in growth and consistency.
View details
D
Diligent Media Corporation Ltd
Diligent Media Corporation Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
L
Lords Mark India Ltd
Lords Mark India Ltd shows potential in a promising sector, but faces challenges in profitability and market sentiment.
View details
B
Bhaskar Agro Chemicals Ltd
Bhaskar Agro Chemicals Ltd shows potential but faces significant challenges in growth consistency and profitability metrics.
View details
S
Shreyas Intermediates Ltd
Shreyas Intermediates Ltd presents a risky investment profile with several concerns regarding growth consistency and market sentiment.
View details
K
Keerthi Industries Ltd
Keerthi Industries Ltd shows potential but faces challenges in execution and market perception. Caution is advised.
View details
A
Agni Green Power Ltd
Agni Green Power Ltd shows potential but faces significant challenges in growth and profitability metrics.
View details
C
Citadel Realty and Developers Ltd
Citadel Realty and Developers Ltd shows potential but faces significant challenges in growth consistency and valuation. Caution is advised for investors.
View details
J
Jagan Lamps Ltd
Jagan Lamps Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
Business Overview
Lasa Supergenerics Ltd is a leading player in the pharmaceutical and agrochemical sectors, specializing in the production of high-quality active pharmaceutical ingredients (APIs) and intermediates. Catering primarily to domestic and international markets, the company is committed to innovation and sustainability. With a strong focus on research and development, Lasa aims to enhance healthcare accessibility while ensuring environmental responsibility. This makes it a valuable choice for investors seeking growth in the healthcare sector.
- Leading manufacturer of APIs and intermediates
- Strong commitment to R&D and innovation
- Focus on sustainability and environmental responsibility
- Expanding presence in domestic and international markets
- Contributes to improved healthcare accessibility
Investment Thesis
Lasa Supergenerics Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. The company's robust fundamentals and strategic positioning in the market make it a noteworthy choice for retail investors.
- Strong promoter group with a proven track record enhances investor confidence.
- Expanding digital services segment offers substantial growth runway.
- Attractive valuation metrics compared to industry peers indicate potential upside.
- Focus on quality products and innovation supports long-term sustainability.
- Positive market sentiment and increasing demand for generics bolster growth prospects.
Opportunity vs Risk
Opportunities
- Growing demand for herbal products
- Expansion into new markets
- Strong brand recognition
- Strategic partnerships with retailers
Risks ⚠️
- Regulatory changes affecting herbal industry
- Intense competition from established players
- Supply chain disruptions
- Fluctuating raw material costs
Peer Perspective
Lasa Supergenerics Ltd trades at a discount to peers like Aarti Drugs and Granules India, reflecting concerns over margin stability. A sustained improvement in profitability could trigger a rerating in its valuation.
Future Outlook
Lasa Supergenerics Ltd is well-positioned for growth, driven by strong demand for its products. Successful execution of its strategic initiatives and effective cost control will be crucial to maximize shareholder value in the coming years.
AI FAQs for Retail Users
- Q: What does Lasa Supergenerics Ltd do?A: Lasa Supergenerics Ltd manufactures and sells pharmaceutical products, focusing on generics and active pharmaceutical ingredients.
- Q: Is Lasa Supergenerics Ltd a profitable company?A: Profitability can vary; it's best to review recent financial statements for current performance.
- Q: What are the risks of investing in Lasa Supergenerics Ltd?A: Risks include market competition, regulatory changes, and fluctuations in raw material costs.
- Q: How can I buy shares of Lasa Supergenerics Ltd?A: Shares can be purchased through a registered stockbroker or online trading platform.
- Q: What is the company's growth strategy?A: Lasa Supergenerics focuses on expanding its product portfolio and increasing market reach.
📊 Stock Investment Checklist (100 Points)
Lasa Supergenerics Ltd • Updated: 2025-09-17 03:18:26
-
10BusinessHighThe sector is growing, but competition is increasing.
-
10GrowthHighConsistent revenue growth observed over the past few years.
-
10ProfitabilityHighROE and ROCE are decent, but cash flow is inconsistent.
-
8ValuationHighValuation metrics are slightly above industry average.
-
7BalanceHighModerate debt levels, but liquidity is adequate.
-
6GovernanceGoodPromoter holding is strong, but some pledging exists.
-
5DriversGoodGrowth drivers are present, but execution risks are notable.
-
5TechnicalsGoodMarket sentiment is neutral with low liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
Lasa Supergenerics Ltd shows potential for growth, but investors should be cautious due to execution risks and competitive pressures.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 70/100
- Growth Potential: 65/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100